27 related articles for article (PubMed ID: 15492833)
1. Silencing of interferon regulatory factor gene 6 in melanoma.
Nobeyama Y; Nakagawa H
PLoS One; 2017; 12(9):e0184444. PubMed ID: 28877249
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.
Gao L; van den Hurk K; Nsengimana J; Laye JP; van den Oord JJ; Beck S; Gruis NA; Zoutman WH; van Engeland M; Newton-Bishop JA; Winnepenninckx VJ; van Doorn R
J Invest Dermatol; 2015 Sep; 135(9):2328-2331. PubMed ID: 25918983
[No Abstract] [Full Text] [Related]
3. Non-Professional Phagocytosis Increases in Melanoma Cells and Tissues with Increasing E-Cadherin Expression.
Unseld LH; Hildebrand LS; Putz F; Büttner-Herold M; Daniel C; Fietkau R; Distel LV
Curr Oncol; 2023 Aug; 30(8):7542-7552. PubMed ID: 37623028
[TBL] [Abstract][Full Text] [Related]
4. Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer.
Dong B; Qiu Z; Wu Y
Front Pharmacol; 2020; 11():596239. PubMed ID: 33343366
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation in malignant melanoma.
Schinke C; Mo Y; Yu Y; Amiri K; Sosman J; Greally J; Verma A
Melanoma Res; 2010 Aug; 20(4):253-65. PubMed ID: 20418788
[TBL] [Abstract][Full Text] [Related]
7. Multifactorial regulation of E-cadherin expression: an integrative study.
Reinhold WC; Reimers MA; Lorenzi P; Ho J; Shankavaram UT; Ziegler MS; Bussey KJ; Nishizuka S; Ikediobi O; Pommier YG; Weinstein JN
Mol Cancer Ther; 2010 Jan; 9(1):1-16. PubMed ID: 20053763
[TBL] [Abstract][Full Text] [Related]
8. Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer.
Fearon ER
Cancer Cell; 2003 Apr; 3(4):307-10. PubMed ID: 12726856
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation.
McGuinness C; Wesley UV
Front Biosci; 2008 Jan; 13():2435-43. PubMed ID: 17981724
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines.
Tsutsumida A; Hamada J; Tada M; Aoyama T; Furuuchi K; Kawai Y; Yamamoto Y; Sugihara T; Moriuchi T
Int J Oncol; 2004 Nov; 25(5):1415-21. PubMed ID: 15492833
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
12. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail.
Poser I; Domínguez D; de Herreros AG; Varnai A; Buettner R; Bosserhoff AK
J Biol Chem; 2001 Jul; 276(27):24661-6. PubMed ID: 11323412
[TBL] [Abstract][Full Text] [Related]
13. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
[TBL] [Abstract][Full Text] [Related]
14. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
[TBL] [Abstract][Full Text] [Related]
15. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
